OverviewChartNewsTraderScreen

HSBC Call 35 FRE 16.12.2026/  DE000HS3RZK4  /

Frankfurt Zert./HSBC
15/08/2024  21:35:26 Chg.0.000 Bid15/08/2024 Ask15/08/2024 Underlying Strike price Expiration date Option type
0.390EUR 0.00% 0.390
Bid Size: 20,000		 0.430
Ask Size: 20,000		 FRESENIUS SE+CO.KGAA... 35.00 - 16/12/2026 Call
GlobeNewswire 16/05 American Oncology Network Appoints New Board Member
GlobeNewswire 23/04 Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
TeleTrader 15/01 Europe closes lower after data
GlobeNewswire 04/01 Sigyn Therapeutics Releases Letter to Shareholders
TeleTrader 17/11/2023 Europe opens higher ahead of CPI figures
GlobeNewswire 09/11/2023 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
TeleTrader 02/11/2023 Europe opens higher ahead of BoE decision
GlobeNewswire 04/09/2023 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 31/08/2023 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
TeleTrader 11/07/2023 Europe opens mostly higher with data, NATO in focus
TeleTrader 23/12/2022 Europe closes mixed ahead of Christmas
TeleTrader 31/10/2022 Europe closes mostly higher, inflation hits new record
GlobeNewswire 25/02/2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
TeleTrader 22/02/2022 Europe closes mostly lower amid Ukraine worries
GlobeNewswire 03/02/2022 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
TeleTrader 17/01/2022 Europe opens higher amid the Forum, COVID data
GlobeNewswire 05/01/2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire 31/12/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire 09/12/2021 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire 22/11/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 22/11/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 12/11/2021 Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire 08/11/2021 Cara Therapeutics Reports Third Quarter 2021 Financial Results
GlobeNewswire 27/10/2021 CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire 26/10/2021 Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...